Guided Therapeutics, Inc. (GTHP)

Market Cap	5.56M
Revenue (ttm)	98,000
Net Income (ttm)	-3.59M
Shares Out	55.61M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,219
Open	0.100
Previous Close	0.091
Day's Range	0.089 - 0.108
52-Week Range	0.062 - 0.300
Beta	0.62
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2023

About GTHP

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 199...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 1, 1997
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Financial Performance

In 2023, GTHP's revenue was $98,000, an increase of 653.85% compared to the previous year's $13,000. Losses were -$3.49 million, -29.83% less than in 2022.